Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://tacticaltherapeutics.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Home - Tactical |
Description | Glioblastoma Executive Summary Glioblastoma Management Team Clinical Trials CTO Overview CTO Overview Mechanism of Action Preclinical Results Intellectual Property Pip |
Keywords | N/A |
WebSite | tacticaltherapeutics.com |
Host IP | 64.207.139.233 |
Location | United States |
Site | Rank |
US$2,483,929
Last updated: 2023-05-08 21:34:15
tacticaltherapeutics.com has Semrush global rank of 4,261,114. tacticaltherapeutics.com has an estimated worth of US$ 2,483,929, based on its estimated Ads revenue. tacticaltherapeutics.com receives approximately 286,608 unique visitors each day. Its web server is located in United States, with IP address 64.207.139.233. According to SiteAdvisor, tacticaltherapeutics.com is safe to visit. |
Purchase/Sale Value | US$2,483,929 |
Daily Ads Revenue | US$2,293 |
Monthly Ads Revenue | US$68,786 |
Yearly Ads Revenue | US$825,429 |
Daily Unique Visitors | 19,108 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
tacticaltherapeutics.com. 7200 | A | tacticaltherapeutics.com. 7200 | IP: 64.207.139.233 |
tacticaltherapeutics.com. 14400 | NS | tacticaltherapeutics.com. 14400 | NS Record: dns101.register.com. |
tacticaltherapeutics.com. 14400 | NS | tacticaltherapeutics.com. 14400 | NS Record: dns102.register.com. |
tacticaltherapeutics.com. 3600 | MX | tacticaltherapeutics.com. 3600 | MX Record: 10 d223849a.ess.barracudanetworks.com. |
tacticaltherapeutics.com. 3600 | MX | tacticaltherapeutics.com. 3600 | MX Record: 20 d223849b.ess.barracudanetworks.com. |
tacticaltherapeutics.com. 14400 | TXT | tacticaltherapeutics.com. 14400 | TXT Record: google-site-verification=e3mWgKDgXjQWGU_fVd4uu37aRHS265YexSYL0VSi0Ww |
tacticaltherapeutics.com. 3600 | TXT | tacticaltherapeutics.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Executive Summary Glioblastoma Management Team Clinical Trials CTO Overview CTO Overview Mechanism of Action Preclinical Results Intellectual Property Pipeline Publications Abstracts Articles Press Releases Contact Tactical Therapeutics Overcoming Resistance in Malignant Brain Cancer Glioblastoma Glioblastoma (grade IV astrocytoma) is an aggressive primary brain tumor that is extremely difficult to treat. There is an unmet medical need for treatment as the current prognosis is only 8.7% of patients surviving two years. The Discovery of CTO While working as a patent attorney, Dr. Karmali had a client with a promising therapeutic for multiple cancerous indications. The client was interested in evaluating the therapy for prostate cancer. Clinical Results of CTO Two recent phase I studies of CTO in a refractory patient populations demonstrated that: CTO is safe and tolerable and has yet to reach MTD at up to 555 mg/m2/day, and therapeutically relevant CAI levels were demonstrated at 219 |
Domain Name: TACTICALTHERAPEUTICS.COM Registry Domain ID: 408247665_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2020-09-25T15:22:08Z Creation Date: 2006-04-11T14:55:50Z Registry Expiry Date: 2026-04-11T14:55:50Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS101.REGISTER.COM Name Server: DNS102.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T04:13:29Z <<< |